Leukemia among male construction workers in California, 1988-2007

Leukemia & Lymphoma
Sara E LuckhauptGeoffrey M Calvert

Abstract

A total of 18 708 male cases of leukemia from the California Cancer Registry, including 1703 cases usually employed in construction, were each matched with up to five controls from the same source who were diagnosed with cancers not thought to be related to exposures common in construction. Compared to other workers, construction workers were found to have a significantly elevated risk for all leukemia combined (morbidity odds ratio [MOR] = 1.14, 95% confidence interval [CI] = 1.08, 1.20), acute lymphocytic leukemia (ALL) (MOR = 1.30, 95% CI = 1.07, 1.58), acute myeloid leukemia (AML) (MOR = 1.15, 95% CI = 1.03, 1.27) and chronic myeloid leukemia (CML) (MOR = 1.25, 95% CI = 1.09, 1.44). Among the different construction occupations, the highest MOR for all leukemia was among carpet installers (MOR = 1.99, 95% CI = 1.16, 3.44), followed by plumbers (MOR = 1.28, 95% CI = 1.03, 1.59) and laborers (MOR = 1.26, 95% CI = 1.12, 1.42). Other associations were limited to specific construction occupations, leukemia subtypes and/or racial/ethnic groups. These associations should be further studied with more in-depth exposure assessment.

References

Jan 1, 1991·American Journal of Industrial Medicine·N E Hall, K D Rosenman
Jan 1, 1988·American Journal of Industrial Medicine·T R O'Brien, P Decouflé
Jun 1, 1986·American Journal of Epidemiology·F B SternW E Murray
Jan 1, 1987·The Journal of the Society of Occupational Medicine·R A CartwrightD A Scarisbrick
Feb 1, 1986·Scandinavian Journal of Work, Environment & Health·G M MatanoskiM L Johnson
Jan 1, 1984·American Journal of Industrial Medicine·H CheckowayH Tyroler
Jun 1, 1984·American Journal of Epidemiology·D H GarabrantL Bernstein
Jul 1, 1981·American Journal of Epidemiology·O S Miettinen, J D Wang
Oct 1, 1993·American Journal of Industrial Medicine·G BurkhartK Ringen
Jul 1, 1997·American Journal of Industrial Medicine·F Stern, M Haring-Sweeney
Jan 10, 1998·Journal of Occupational and Environmental Medicine·L I KheifetsC C Matkin
Apr 16, 1998·Occupational and Environmental Medicine·M KogevinasS Hoar-Zahm
Nov 21, 1998·Cancer Detection and Prevention·R Chen, A Seaton
Feb 19, 1999·Journal of Epidemiology and Community Health·C Poole, K J Rothman
Dec 17, 2004·Journal of Occupational and Environmental Medicine·Paolo Boffetta
Jan 12, 2005·Journal of Occupational and Environmental Medicine·Orlando Gómez-MarínTerry Pitman
Nov 23, 2006·Annals of the New York Academy of Sciences·Bengt Järvholm
Jul 11, 2008·Journal of Occupational and Environmental Hygiene·Pamela R D WilliamsDennis J Paustenbach
Oct 28, 2008·International Journal of Epidemiology·David McLeanNeil Pearce
Feb 12, 2009·British Journal of Cancer·K Y WolinI-M Lee
Nov 21, 2009·Acta Oncologica·Eero PukkalaKristina Kjaerheim
Jan 23, 2010·American Journal of Industrial Medicine·Kerry SouzaSherry L Baron
Apr 29, 2010·British Journal of Cancer·L RushtonS J Hutchings
Jan 13, 2012·American Journal of Industrial Medicine·Geoffrey M CalvertDennis Deapen

❮ Previous
Next ❯

Citations

Apr 12, 2013·Occupational and Environmental Medicine·Fatemeh Saberi HosnijehRoel Vermeulen
Aug 19, 2014·Current Hematologic Malignancy Reports·L A Anderson, M F McMullin
Feb 20, 2014·Leukemia & Lymphoma·Rebecca J TsaiGeoffrey M Calvert
Jul 12, 2017·American Journal of Industrial Medicine·MaryBeth B FreemanUNKNOWN enhancement of NPCR for comparative effectiveness research team
Oct 30, 2013·Hand Surgery : an International Journal Devoted to Hand and Upper Limb Surgery and Related Research : Journal of the Asia-Pacific Federation of Societies for Surgery of the Hand·Hideaki MiyamotoSakae Tanaka

❮ Previous
Next ❯

Related Concepts

Related Feeds

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.